Chromatography Resin Market Research Report Information By Type (Natural Resin, Synthetic Resin, Inorganic Media) Technique (Ion-exchange chromatography, Affinity chromatography, Hydrophobic interaction chromatography, Size exclusion chromatography, Multi-modal chromatography, Others) Forecast 2032

Chromatography Resin Market Summary

As per Market Research Future Analysis, the global chromatography resin market was valued at USD 14,594.77 Million in 2023 and is projected to grow to USD 26,607.04 Million by 2032, with a CAGR of 6.90% from 2024 to 2032. Chromatography resins are essential for isolating components in pharmaceuticals and biotechnology, particularly in the development of vaccines and treatments. The COVID-19 pandemic positively impacted the market due to increased demand for analytical methods in vaccine development. However, high costs associated with affinity resins, particularly Protein A, pose challenges. Opportunities exist in the growing demand for biosimilars, which offer cost-effective alternatives to branded biologics. Trends indicate a shift towards green chromatography to reduce environmental impact.

Key Market Trends & Highlights

The chromatography resin market is witnessing significant trends and dynamics.

• COVID-19 has increased demand for chromatography techniques, enhancing market growth.
• The market is driven by the pharmaceutical and biotechnology sectors, with HPLC being a key analytical method.
• High costs of affinity resins, particularly Protein A, account for over 60% of downstream expenses in mAb therapies.
• Growing demand for biosimilars is expected to provide cost-effective alternatives to existing biologics.

Market Size & Forecast

2023 Market Size: USD 14,594.77 Million

2032 Market Size: USD 26,607.04 Million

CAGR (2024-2032): 6.90%

Largest Regional Market Share in 2021: North America.

Major Players

Key players include Tosoh Corporation, Thermo Fisher Scientific Inc, Repligen Corporation, Avantor Performance Materials Inc, Merck KGaA, Bio-Rad Laboratories Inc, Pall Corporation, Mitsubishi Chemical Corporation, GE Healthcare, R. Grace & Co, and Purolite Corporation.

Chromatography is a process to split or separate a blend of colored components into individual elements. Chromatography resins help in the isolation of desired components from a mixture of compounds. They are incorporated into chromatography devices and are used in diagnostic test development and separation of biomolecules. Choice of resins is very crucial to ensure an effective and accurate separation of individual components.

Chromatography resins are media used to capture and polish mAbs, antibody fragments, vaccines, and other biomolecules using a stationary phase. There are multiple types of ion-exchange resin. Most commercial resins are made of polystyrene sulfonate.

COVID-19 Impact on the Chromatography Resin Market

The outbreak of COVID-19 has had a positive impact on the global chromatography resin market. This is attributed to the development of effective vaccines and treatments by companies and governments worldwide, which resulted in the employment of robust analytical methods by researchers across the globe.

Researchers used chromatography, a strong laboratory-based analytical approach, to better understand the Sars-CoV-2 virus and develop new medicines, vaccines, and diagnostic tools to aid in the fight against the Covid-19 epidemic. Because of its central role in viral pathogenesis, the SARS-CoV-2 virus's spike protein has piqued researchers' interest as a vaccine target. While many researchers have attempted to classify the spike protein's glycopeptides and glycans, intact protein analysis utilizing reversed-phase liquid chromatography (RPLC) may provide novel analytical insights. More effective medicines can be identified and developed by refining functional and structural understanding of the intact spike protein. Liquid chromatography coupled with mass spectrometry was used to quantify remdesivir in the blood plasma of a COVID-19 patient and thus provide data on its efficacy as a treatment for SARS-CoV-2.

The crucial need for developing the effective treatment for COVID-19 during the year 2020 resulted in high demand for chromatographic techniques, thus, having a positive impact on the global market.

Chromatography Resin Market Dynamics

Drivers

• Use of chromatography techniques in pharmaceuticals & biotechnology industry: The HPLC chromatography technique is considered the most important analytical technique used in the pharmaceutical business to identify and quantify pharmaceuticals. This is used either in the active pharmaceutical ingredient or in the formulations during the research, development, and production of a medicine. The chromatography methods are accurate, precise, quick, specific, and easy; therefore, they are widely used for regular quality control examination of medicines in bulk and pharmaceutical dosage form. They can be used in drug research and development, drug impurity analysis, assay, content uniformity, and drug method development and validation. HPLC's capacity to reveal the structure and determine the amounts of contaminants in pharmaceutical formulations is one of its key advantages. HPLC is particularly well suited to chemicals that are difficult to volatilize, are thermally unstable, and have large molecular weights. As a result, it can measure a medication in both its pure and dose form.

Restraints

• High cost of affinity resins: In a typical platform process for the manufacturing of mAb therapies, the steps following fermentation account for over 80% of the total process costs, with chromatography accounting for up to 60% of the downstream expenses. Protein A resin is the most significant contributor to the entire cost. Traditional chromatographic medium with non-proteinaceous ligands cost roughly half as much as Protein A resin. The cost of resin for a large column (diameter >1 m) can surpass USD 1 million. The fact that most antibody therapies require frequent and substantial doses of Protein A makes the expense of Protein A resin even more difficult.

Opportunity

• Increasing demand for biosimilars: Each biosimilar is made using the same amino acid starting materials and the same precise, step-by-step processes as its reference drug — a well-tested, widely-used biologic drug that’s already been on the market for years. All biosimilars are prescription drugs. Biosimilars are intended to provide a more cost-effective alternative to high-priced branded biologics. This will help in easy accessibility of medicines and appropriate therapies for the patients.

Trends

• Adoption of green chromatography: To lessen the risks to the environment and human health associated with the use of chromatography, scientists have modified the technology such that non-toxic chemicals can be used instead of toxic ones where possible, and the energy consumption is lowered and derived from renewable sources. Acetonitrile, a volatile organic molecule, is the most widely used solvent in chromatography. According to studies, a mixture of propylene carbonate–ethanol–water can be used to substitute this harmful solvent with equivalent efficacy. Other research has indicated that a mixture of ethyl acetate and ethanol can be utilized as a more environmentally acceptable alternative to acetonitrile. Solutions of 0.04% triethylamine in water are also an effective alternative for toxic chemicals used in chromatography

Segmentation

By Type

• Natural Resin
• Synthetic Resin
• Inorganic Media

By Technique

• Ion-exchange chromatography
• Affinity chromatography
• Hydrophobic interaction chromatography
• Size exclusion chromatography
• Multi-modal chromatography
• Others

By Application

• Pharmaceuticals & biotechnology
• Food & beverages
• Water & environment analysis
• Academics & research
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Regional Analysis

The Global Chromatography resin Market has been studied across five regions: North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa. North America accounted for a largest market share in 2021. The North American market has been divided into the US and Canada. The US was the largest pharmaceutical market in 2021, generating about USD 12,771.5 million representing around 40% of the global revenue generated worldwide. According to AstraZeneca, North America is expected to continue to lead global pharmaceutical sales in the year 2022 with USD 13,279.8 million.

Asia-Pacific accounted for 21.30% of the global market share in 2021 and is expected to reach a value of USD 22,750.0 million by the end of the forecast period. The growth of the region can be associated with the growth of the pharmaceutical industry in China, India, and Japan.

China has solidified its position as a key player in the global pharmaceutical sector, both as a consumer and as a base for expanding R&D. Domestic and global pharmaceutical companies are expanding and introducing new products in China, which is a key factor for the growth of the chromatography resin market.

Competitive Landscape

Chromatography resin market is expected to register healthy growth throughout the forecast period. The market represents strong numbers in terms of consumption and is expected to grow year on year. Chromatography resin market is highly fragmented, with presence of numerous tier-1, tier-2, and unorganized players.

Some of the key players operating in chromatography resin market Tosoh Corporation (Japan), Thermo Fisher Scientific Inc (US), Repligen Corporation (US), Avantor Performance Materials Inc (US), Merck KGaA (Germany), Bio-Rad Laboratories Inc (US), Pall Corporation (US), Mitsubishi Chemical Corporation (Japan), GE Healthcare (US), R.Grace & Co (US) and Purolite Corporation (US).

Chromatography Resin Market Industry Developments

• Q2 2024: Cytiva opens new chromatography resin manufacturing facility in Uppsala, Sweden Cytiva inaugurated a new state-of-the-art facility in Uppsala to expand its production capacity for chromatography resins, aiming to meet growing global demand from the biopharmaceutical sector.
• Q2 2024: Bio-Rad Laboratories launches new mixed-mode chromatography resin for bioprocessing Bio-Rad announced the commercial launch of a novel mixed-mode chromatography resin designed to improve purification efficiency for monoclonal antibodies and other biologics.
• Q3 2024: Thermo Fisher Scientific expands chromatography resin portfolio with new affinity resin Thermo Fisher introduced a new affinity chromatography resin targeting the purification of next-generation biologics, enhancing its offering for pharmaceutical manufacturers.
• Q3 2024: Purolite announces partnership with major Asian biopharma for custom resin supply Purolite entered a multi-year supply agreement with a leading Asian biopharmaceutical company to provide custom chromatography resins for large-scale therapeutic protein production.
• Q4 2024: Repligen acquires chromatography resin technology from private biotech firm Repligen completed the acquisition of proprietary chromatography resin technology, strengthening its position in the downstream bioprocessing market.
• Q1 2025: Merck KGaA opens new chromatography resin R&D center in Darmstadt, Germany Merck inaugurated a dedicated research and development center focused on advancing chromatography resin technologies for pharmaceutical and biotech applications.
• Q1 2025: Tosoh Corporation launches high-capacity ion exchange resin for vaccine purification Tosoh introduced a new ion exchange chromatography resin specifically engineered for high-throughput vaccine purification processes.
• Q2 2025: Agilent Technologies announces strategic partnership with European CDMO for resin supply Agilent entered a strategic partnership to supply chromatography resins to a major European contract development and manufacturing organization (CDMO) supporting biologics production.
• Q2 2025: Bio-Rad Laboratories appoints new VP of Chromatography Business Unit Bio-Rad named a new Vice President to lead its Chromatography Business Unit, signaling a renewed focus on innovation and global expansion in resin technologies.
• Q3 2025: Thermo Fisher Scientific secures multi-year contract to supply chromatography resins to top-10 pharma company Thermo Fisher signed a multi-year supply agreement with a leading global pharmaceutical company for chromatography resins used in large-scale biologics manufacturing.
• Q3 2025: Cytiva launches sustainable chromatography resin line with reduced environmental footprint Cytiva introduced a new line of chromatography resins manufactured using sustainable processes and materials, targeting environmentally conscious bioprocessing customers.
• Q4 2025: Repligen announces $100 million investment in US chromatography resin manufacturing expansion Repligen revealed plans to invest $100 million to expand its US-based chromatography resin manufacturing capacity, aiming to address supply chain resilience and rising demand.

Report Overview:

The Chromatography resin market is segmented by Type, Technique, application, and region in the report. In terms of insights, this report has focused on various levels of analysis such as market dynamics, value chain analysis, Porter's five forces, competitive landscape, and company profiles—all of which comprise and discuss views on the global chromatography resin emerging and fast-growing segments, regions, and countries.

Objectives of the Study

• To get a comprehensive overview of the global chromatography resin market
• To get wide-ranging information about the key factors driving the market and market opportunities
• To gain information regarding the key players in the industry, their product portfolio, strategies, and key developments
• To gain insights about the key country/region in which the market is growing

Intended Audience

• Industrial sector
• Academics
• Pharmaceutical industries
• Agrochemical industries

Report Attribute/Metric	Details
Market Size 2023	USD  14594.77 Million
Market Size 2024	USD 15601.81 Million
Market Size 2032	USD 26607.04 Million
Compound Annual Growth Rate (CAGR)	6.90% (2024-2032)
Base Year	2023
Market Forecast Period	2024-2032
Historical Data	2018 & 2020
Market Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Application, End-Use Industry
Geographies Covered	North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered	The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Tosoh Corporation (Japan), Thermo Fisher Scientific Inc (US), Repligen Corporation (US), Avantor Performance Materials Inc (US), Merck KGaA (Germany), Bio-Rad Laboratories Inc (US), Pall Corporation (US), Mitsubishi Chemical Corporation (Japan), GE Healthcare (US), R.Grace & Co (US) and Purolite Corporation (US).
Key Market Opportunities	Use of chromatography techniques in pharmaceuticals & biotechnology industry
Key Market Dynamics	Increasing demand for biosimilars